Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2026)

Roivant Sciences (ROIV) has reported Interest & Investment Income for 6 consecutive years, with $36.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income fell 23.59% year-over-year to $36.9 million; the trailing twelve-month figure through Jun 2026 stood at $224.8 million (down 42.95% YoY), and the FY2026 full-year result was $178.1 million, down 31.07% from the prior year.
• Interest & Investment Income declined to $36.9 million in Q2 2026 per ROIV's latest filing, from $136.9 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $203.8 million in Q4 2024 and bottomed at $2.0 million in Q2 2022.
• Historically, Interest & Investment Income has averaged $53.1 million across 5 years, with a median of $36.9 million in 2026.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 9045.16% in 2022, then slumped 96.3% in 2025.
• Over 5 years, Interest & Investment Income stood at $17.9 million in 2022, then soared by 251.77% to $63.0 million in 2023, then soared by 223.58% to $203.8 million in 2024, then sank by 32.8% to $136.9 million in 2025, then tumbled by 73.04% to $36.9 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $36.9 million, $136.9 million, and $2.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.